Tesla market value crosses $500 billion in meteoric rally
FILE PHOTO: The Tesla logo is seen at the entrance to Tesla Motors' showroom in Manhattan's Meatpacking District in New York City, U.S., December 14, 2017. REUTERS/Brendan McDermid/File Photo
By Subrat Patnaik and Noel Randewich
(Reuters) - Tesla Inc blew past $500 billion in market value on Tuesday as investors snapped up its shares in the run-up to its debut in the S&P 500, extending a meteoric rally that has seen it surge over 500% this year.
The California electric carmaker's stock rose nearly 5%, putting its market capitalization at $519 billion.
Tesla is Wall Street's seventh most valuable company, just behind Berkshire Hathaway , and its shares have rallied over 30% since Nov. 16, when it was announced Tesla would join the S&P 500 benchmark.
Index funds that replicate the S&P 500 will have to buy more than $50 billion worth of Tesla's stock ahead of its inclusion to the index on Dec. 21. Additionally, Goldman Sachs estimated last week that actively managed mutual funds could buy another $8 billion of Tesla shares after it is added.
Tesla has become by far the world's most valuable automaker, despite production that is a fraction of Toyota Motor Corp, Volkswagen or General Motors Co.
Shares of other electric vehicle (EV) makers have also rallied in recent months as President-elect Joe Biden made boosting EVs a top priority during his campaign.
Chinese electric carmaker Nio Inc fell 4.9% on Tuesday, trimming its gain in November to 72%.
"One of the core underpinnings of the Biden platform will be around pushing clean energy and zero-emissions vehicles with hopes of accelerating the deployment of electric vehicles and public charging outlets by 2030," Wedbush analyst Daniel Ives wrote in a research note.
(Reporting by Subrat Patnaik in Bengaluru and Noel Randewich in San Francisco; Editing by Tom Brown)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla (TSLA) Reiterated at Buy by StoneX Ahead of Q3 Deliveries Data Next Week
- This Is The Top REIT Stock Stifel Analysts Are Backing Right Now
- Regenxbio stock gains on positive gene therapy trial data
Create E-mail Alert Related Categories
General News, ReutersRelated Entities
Warren Buffett, Goldman Sachs, Second Curve Capital, TeslaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share